UBS downgrades DraftKings stock rating on valuation concerns

UBS downgraded DraftKings to Neutral from Buy and cut its price target to $22 from $48, citing uncertainty around valuing the prediction-markets business, approximately $1 billion in losses there, and decelerating core revenue growth. The stock was down 15% over the past week and 46% year-to-date; UBS said its mid- to high-single-digit core revenue growth forecast may be optimistic. DraftKings’ Q3 2026 revenue rose 16% to $1.33 billion but missed consensus by 4.2%, while adjusted loss per share of $0.53 exceeded the expected $0.36 loss, contributing to a major reduction in full-year guidance.

Analysis

The key issue is not the downgrade itself but a deterioration in the quality of earnings: spending on a new, regulation-sensitive business is absorbing capital while core growth is decelerating and execution has missed across segments. High gross margins do not protect equity value if customer acquisition, promotions, and platform investment consume the contribution before corporate costs. Prediction markets also create a potential strategic trade-off: they may broaden engagement, but could divert product and marketing resources from the sportsbook/iGaming franchise without a dependable path to monetization.

Near term, another guidance reset or evidence that core growth is slowing would likely outweigh any perceived cheapness; after the sharp drawdown, however, chasing a short risks a relief rally if results stabilize. Over 1–3 months, track quarterly core sportsbook/iGaming growth, adjusted loss and cash investment in Predictions, and regulatory developments in markets where the product operates. Over 6–18 months, the central question is whether Predictions becomes a separately valuable, compliant revenue stream or remains a drag that merits little or no incremental valuation.

The contrarian risk to the bearish case is that expectations and the multiple may already have reset materially. A sustained improvement in core growth alongside declining incremental investment would challenge the downgrade thesis. Conversely, another core-growth deceleration or higher-than-guided losses would falsify the view that the existing price adequately reflects execution risk.

Key Decisions for Investors

• Do not add to DKNG solely on an undervaluation screen; require evidence that core growth is stabilizing and investment losses are moderating. The reported gross margin is not a substitute for proof of operating leverage.
• For existing exposure, use any relief rally to reduce risk rather than treating the analyst target as a floor. Reassess after the next earnings/guidance update, focusing on core sportsbook/iGaming growth, adjusted losses, and cash spent on Predictions.
• Tactical bearish trade: consider a defined-risk put spread only if implied volatility is not already pricing an outsized further decline; otherwise wait for a failed rebound or a confirming guidance cut before initiating a short. The stock’s substantial prior decline makes an immediate unhedged short vulnerable to a sharp squeeze.
• Monitor regulatory decisions and product-level investment/disclosure. A clear regulatory setback or continued investment without measurable monetization supports further downside; improving core growth with narrowing losses would invalidate the bearish setup.